<p>Tilray Brands, Inc.（纳斯达克代码：TLRY - 获取免费报告）在周五的交易中股价下跌了 2.7%。该公司的股价最低曾达到 6.65 美元，最后交易价为 6.75 美元。在午盘交易中，共交易了 8,470,793 股，较平均交易量 4,503,807 股增加了 88%。该股票之前的收盘价为 6.94 美元。</p>
<p>获取 <strong>Tilray Brands</strong> 的提醒：</p>
<h2>Tilray Brands 重要新闻</h2>
<ul>
<li>大麻行业的十亿美元减税</li>
</ul>
<p>以下是本周影响 Tilray Brands 的主要新闻：</p>
<ul>
<li>积极情绪：联邦重新分类（从第一类到第三类）显著改善了美国大麻运营商的税收前景，并引发了行业反弹；虽然 Tilray 更像是一个全球/手工饮料的参与者（因此是一个同情受益者），但政策变化对大麻投资者情绪总体上是利好的。阅读更多。</li>
<li>积极情绪：Tilray 发布声明，表明公司将加速美国医疗扩展，并强调其品牌饮料和健康渠道，为潜在的上行提供了叙述，如果监管准入实现。阅读更多。</li>
<li>积极情绪：大量异常的看涨期权购买表明投机性看涨头寸，可能会放大日内反弹（和波动性）。阅读更多。</li>
<li>积极情绪：至少一位华尔街分析师（Roth Capital）持乐观态度，并给 Tilray 设定了一个可观的上行情景，这支持了动量驱动的买入。阅读更多。</li>
<li>中性情绪：首席执行官的采访和媒体报道强化了公司围绕美国机会的战略叙述，但管理层尚未提供具体的新美国收入或时间表指导。阅读更多。</li>
<li>中性情绪：在日内激增期间，交易经历了 LULD/波动暂停——这是一种市场机制，反映了快速变动而非基本面的变化。（没有单一文章；在市场报道中提及。）</li>
<li>消极情绪：内部人士抛售：一名公司董事出售了 33,556 股（已披露的 4 号表格），交易员对此表示关注，可能导致了获利了结。阅读更多。</li>
<li>消极情绪：“卖出新闻” 反转和稀释担忧：在第三类标题发布后的早期涨幅消退，交易员获利了结，而一份关于市场发行（最高约 1.8 亿美元）的四月招股说明书重新引发了稀释担忧——给股价施加压力。阅读更多。</li>
<li>消极情绪：日内报道指出，在盘前激增后迅速回落——这一模式（跳涨后回落）强调今天的走势更多是由政策头条和动量交易驱动，而非 Tilray 公司层面的即时收益或现金流改善。阅读更多。</li>
</ul>
<h2>分析师设定新目标价</h2>
<p>多家券商最近对 TLRY 发表了评论。ATB Cormark Capital Markets 在 4 月 2 日的研究报告中将 Tilray Brands 的目标价从 9.50 美元下调至 9.00 美元，并对该股票设定了 “行业表现” 评级。Weiss Ratings 在 1 月 21 日的研究报告中重新发布了对 Tilray Brands 的 “卖出（d-）” 评级。Wall Street Zen 在 3 月 21 日的研究报告中将 Tilray Brands 的评级从 “卖出” 上调至 “持有”。Roth Mkm 在 4 月 2 日的研究报告中将 Tilray Brands 的评级从 “中性” 上调至 “买入”，并设定了 10.00 美元的目标价。最后，TD Cowen 在 3 月 30 日的研究报告中将 Tilray Brands 的目标价从 10.00 美元下调至 7.00 美元，并对该股票设定了 “买入” 评级。三位股票研究分析师对该股票给予了 “买入” 评级，四位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Tilray Brands 的共识评级为 “持有”，平均目标价为 11.50 美元。</p>
<ul>
<li>2026 年大麻黑马：税改如何重置股票估值</li>
</ul>
<p><strong>查看我们关于 Tilray Brands 的最新研究报告</strong></p>
<h2>Tilray Brands 价格表现</h2>
<p>该公司的市值为 7.8671 亿美元，市盈率为-0.49，贝塔值为 2.00。公司的债务与股本比率为 0.19，速动比率为 1.66，流动比率为 2.79。该公司的 50 日移动平均线为 7.03 美元，200 日移动平均线为 9.51 美元。</p>
<ul>
<li>MarketBeat 周报 – 09/29 - 10/03</li>
</ul>
<p>Tilray Brands（纳斯达克代码：TLRY - 获取免费报告）最后一次发布季度财报是在 4 月 1 日，报告显示该季度每股收益（EPS）为-0.24 美元，低于市场共识预期的-0.14 美元，差距为-0.10 美元。该季度的营业收入为 2.0673 亿美元，而市场共识预期为 2.0135 亿美元。Tilray Brands 的净利润率为-156.51%，股本回报率为-3.31%。去年同期，该公司每股收益为-0.87 美元。分析师预测 Tilray Brands, Inc.在当前年度将发布-0.55 美元的每股收益。</p>
<h2>Tilray Brands 的内部交易</h2>
<p>在相关消息中，董事 David G. Hopkinson 在 4 月 21 日的交易中出售了 33,556 股公司的股票。该股票的平均售价为 6.94 美元，总价值为 232,878.64 美元。该交易已在 SEC 的法律文件中披露，可通过 SEC 网站获取。公司内部人士持有公司股票的 0.84%。</p>
<h2>机构投资者对 Tilray Brands 的看法</h2>
<p>对冲基金最近增加或减少了对该股票的持股。Tudor Investment Corp ET AL 在第三季度购买了价值 518,000 美元的 Tilray Brands 新股份。Optiver Holding B.V. 在第三季度将其在 Tilray Brands 的持股增加了 239.4%。Optiver Holding B.V. 目前拥有 224,049 股该公司股票，价值 388,000 美元，此前在上个季度又购买了 158,041 股。Cresset Asset Management LLC 在第三季度将其在 Tilray Brands 的持股增加了 72.1%。Cresset Asset Management LLC 目前拥有 501,989 股该公司股票，价值 868,000 美元，此前在上个季度又购买了 210,267 股。Caitong International Asset Management Co. Ltd 在第三季度将其在 Tilray Brands 的持股增加了 99,204,800.0%。Caitong International Asset Management Co. Ltd 目前拥有 992,049 股该公司股票，价值 1,716,000 美元，此前在上个季度又购买了 992,048 股。最后，Zuckerman Investment Group LLC 在第三季度购买了价值 147,000 美元的 Tilray Brands 新股份。目前，9.35% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Tilray Brands 公司简介</h2>
<p>(获取免费报告)</p>
<p>Tilray Brands, Inc 是一家全球性的 cannabis-lifestyle 和消费包装商品公司，专注于大麻及其衍生产品的种植、生产、分销和销售。该公司开发和营销多样化的品牌产品组合，涵盖医疗大麻、成人娱乐产品和健康产品。通过先进的种植设施、研发努力和质量控制系统，Tilray Brands 旨在为各种患者和消费者需求提供一致、可扩展的产品。</p>
<p>Tilray 的产品线包括大麻花、预卷烟、油和酊剂、电子烟、食品和外用产品，以及大麻衍生的 CBD 产品。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 Tilray Brands</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Tilray Brands 吗？</h2>
<p>在考虑 Tilray Brands 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Tilray Brands 并不在名单上。</p>
<p>虽然 Tilray Brands 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

TLRY

另类收益 ETF -ETFMG

纯大麻 ETF - AdvisorShares

<p>Tilray Brands（纳斯达克代码：TLRY）股价在交易中下跌 2.7%，至 6.75 美元，成交量显著增加。由于联邦对大麻的重新分类，公司周围的情绪积极，这可能会促进美国医疗市场的扩展。然而，内部人士的抛售和稀释担忧对股价表现产生了负面影响。分析师的评级不一，普遍持有评级，平均目标价为 11.50 美元。公司报告每股亏损 0.24 美元，未能达到预期，净利润率为负的 156.51%</p>

<p>Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) shares fell 2.7% during trading on Friday . The company traded as low as $6.65 and last traded at $6.75. 8,470,793 shares were traded during mid-day trading, an increase of 88% from the average session volume of 4,503,807 shares. The stock had previously closed at $6.94.</p>
<div class="lb-trans"><p>Tilray Brands, Inc.（纳斯达克代码：TLRY - 获取免费报告）在周五的交易中股价下跌了 2.7%。该公司的股价最低曾达到 6.65 美元，最后交易价为 6.75 美元。在午盘交易中，共交易了 8,470,793 股，较平均交易量 4,503,807 股增加了 88%。该股票之前的收盘价为 6.94 美元。</p>
</div><p>Get <strong>Tilray Brands</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Tilray Brands</strong> 的提醒：</p>
</div><h2>Key Tilray Brands News</h2>
<div class="lb-trans"><h2>Tilray Brands 重要新闻</h2>
</div><ul>
<li>The Cannabis Sector's Billion-Dollar Tax Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻行业的十亿美元减税</li>
</ul>
</div><p>Here are the key news stories impacting Tilray Brands this week:</p>
<div class="lb-trans"><p>以下是本周影响 Tilray Brands 的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Federal rescheduling (Schedule I → III) materially improves the tax outlook for U.S. cannabis operators and has ignited a sector rally; while Tilray is more of a global/craft‑beverage play (so it's a sympathy beneficiary), the policy shift is broadly bullish for cannabis investor sentiment. Read More.</li>
<li>Positive Sentiment: Tilray issued statements positioning the company to accelerate U.S. medical expansion and highlight its branded beverage and wellness channels, providing a narrative for upside if regulatory access materializes. Read More.</li>
<li>Positive Sentiment: Large, unusual call‑option buying suggests speculative bullish positioning that can amplify intraday rallies (and volatility). Read More.</li>
<li>Positive Sentiment: At least one Wall Street analyst (Roth Capital) is bullish and has given Tilray a sizable upside scenario, which supports momentum-driven buying. Read More.</li>
<li>Neutral Sentiment: CEO interviews and media coverage reinforce the company’s strategic narrative around U.S. opportunity, but management has not yet provided concrete new U.S. revenue or timeline guidance. Read More.</li>
<li>Neutral Sentiment: Trading experienced a LULD/volatility pause during the intraday surge — a market mechanism reflecting fast moves rather than changing fundamentals. (No single article; referenced in market coverage.)</li>
<li>Negative Sentiment: Insider selling: a company director sold 33,556 shares (disclosed Form 4), which traders flagged and may have contributed to profit-taking. Read More.</li>
<li>Negative Sentiment: “Sell‑the‑news” reversal and dilution concerns: early gains after the Schedule III headline faded as traders took profits, and an April prospectus for an at‑the‑market offering (up to ~$180M) resurfaced dilution worries—pressuring the stock. Read More.</li>
<li>Negative Sentiment: Intraday coverage noted rapid fade after the premarket surge — the pattern (jump then giveback) underscores that today's move was driven more by policy headlines and momentum trading than by an immediate, company-level earnings or cash‑flow improvement for Tilray. Read More.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：联邦重新分类（从第一类到第三类）显著改善了美国大麻运营商的税收前景，并引发了行业反弹；虽然 Tilray 更像是一个全球/手工饮料的参与者（因此是一个同情受益者），但政策变化对大麻投资者情绪总体上是利好的。阅读更多。</li>
<li>积极情绪：Tilray 发布声明，表明公司将加速美国医疗扩展，并强调其品牌饮料和健康渠道，为潜在的上行提供了叙述，如果监管准入实现。阅读更多。</li>
<li>积极情绪：大量异常的看涨期权购买表明投机性看涨头寸，可能会放大日内反弹（和波动性）。阅读更多。</li>
<li>积极情绪：至少一位华尔街分析师（Roth Capital）持乐观态度，并给 Tilray 设定了一个可观的上行情景，这支持了动量驱动的买入。阅读更多。</li>
<li>中性情绪：首席执行官的采访和媒体报道强化了公司围绕美国机会的战略叙述，但管理层尚未提供具体的新美国收入或时间表指导。阅读更多。</li>
<li>中性情绪：在日内激增期间，交易经历了 LULD/波动暂停——这是一种市场机制，反映了快速变动而非基本面的变化。（没有单一文章；在市场报道中提及。）</li>
<li>消极情绪：内部人士抛售：一名公司董事出售了 33,556 股（已披露的 4 号表格），交易员对此表示关注，可能导致了获利了结。阅读更多。</li>
<li>消极情绪：“卖出新闻” 反转和稀释担忧：在第三类标题发布后的早期涨幅消退，交易员获利了结，而一份关于市场发行（最高约 1.8 亿美元）的四月招股说明书重新引发了稀释担忧——给股价施加压力。阅读更多。</li>
<li>消极情绪：日内报道指出，在盘前激增后迅速回落——这一模式（跳涨后回落）强调今天的走势更多是由政策头条和动量交易驱动，而非 Tilray 公司层面的即时收益或现金流改善。阅读更多。</li>
</ul>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of brokerages have recently commented on TLRY. ATB Cormark Capital Markets dropped their price target on Tilray Brands from $9.50 to $9.00 and set a &#34;sector perform&#34; rating on the stock in a research report on Thursday, April 2nd. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Tilray Brands in a research report on Wednesday, January 21st. Wall Street Zen raised Tilray Brands from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, March 21st. Roth Mkm raised Tilray Brands from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $10.00 price target on the stock in a research report on Thursday, April 2nd. Finally, TD Cowen lowered their price objective on Tilray Brands from $10.00 to $7.00 and set a &#34;buy&#34; rating on the stock in a research report on Monday, March 30th. Three equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Tilray Brands has a consensus rating of &#34;Hold&#34; and an average price target of $11.50.</p>
<div class="lb-trans"><p>多家券商最近对 TLRY 发表了评论。ATB Cormark Capital Markets 在 4 月 2 日的研究报告中将 Tilray Brands 的目标价从 9.50 美元下调至 9.00 美元，并对该股票设定了 “行业表现” 评级。Weiss Ratings 在 1 月 21 日的研究报告中重新发布了对 Tilray Brands 的 “卖出（d-）” 评级。Wall Street Zen 在 3 月 21 日的研究报告中将 Tilray Brands 的评级从 “卖出” 上调至 “持有”。Roth Mkm 在 4 月 2 日的研究报告中将 Tilray Brands 的评级从 “中性” 上调至 “买入”，并设定了 10.00 美元的目标价。最后，TD Cowen 在 3 月 30 日的研究报告中将 Tilray Brands 的目标价从 10.00 美元下调至 7.00 美元，并对该股票设定了 “买入” 评级。三位股票研究分析师对该股票给予了 “买入” 评级，四位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Tilray Brands 的共识评级为 “持有”，平均目标价为 11.50 美元。</p>
</div><ul>
<li>The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations</li>
</ul>
<div class="lb-trans"><ul>
<li>2026 年大麻黑马：税改如何重置股票估值</li>
</ul>
</div><p><strong>Check Out Our Latest Research Report on Tilray Brands</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Tilray Brands 的最新研究报告</strong></p>
</div><h2>Tilray Brands Price Performance</h2>
<div class="lb-trans"><h2>Tilray Brands 价格表现</h2>
</div><p>The firm has a market capitalization of $786.71 million, a P/E ratio of -0.49 and a beta of 2.00. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. The firm has a 50-day moving average of $7.03 and a 200-day moving average of $9.51.</p>
<div class="lb-trans"><p>该公司的市值为 7.8671 亿美元，市盈率为-0.49，贝塔值为 2.00。公司的债务与股本比率为 0.19，速动比率为 1.66，流动比率为 2.79。该公司的 50 日移动平均线为 7.03 美元，200 日移动平均线为 9.51 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 09/29 - 10/03</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 09/29 - 10/03</li>
</ul>
</div><p>Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The business had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period last year, the company posted ($0.87) earnings per share. As a group, analysts predict that Tilray Brands, Inc. will post -0.55 EPS for the current year.</p>
<div class="lb-trans"><p>Tilray Brands（纳斯达克代码：TLRY - 获取免费报告）最后一次发布季度财报是在 4 月 1 日，报告显示该季度每股收益（EPS）为-0.24 美元，低于市场共识预期的-0.14 美元，差距为-0.10 美元。该季度的营业收入为 2.0673 亿美元，而市场共识预期为 2.0135 亿美元。Tilray Brands 的净利润率为-156.51%，股本回报率为-3.31%。去年同期，该公司每股收益为-0.87 美元。分析师预测 Tilray Brands, Inc.在当前年度将发布-0.55 美元的每股收益。</p>
</div><h2>Insider Transactions at Tilray Brands</h2>
<div class="lb-trans"><h2>Tilray Brands 的内部交易</h2>
</div><p>In related news, Director David G. Hopkinson sold 33,556 shares of the company's stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.84% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 David G. Hopkinson 在 4 月 21 日的交易中出售了 33,556 股公司的股票。该股票的平均售价为 6.94 美元，总价值为 232,878.64 美元。该交易已在 SEC 的法律文件中披露，可通过 SEC 网站获取。公司内部人士持有公司股票的 0.84%。</p>
</div><h2>Institutional Investors Weigh In On Tilray Brands</h2>
<div class="lb-trans"><h2>机构投资者对 Tilray Brands 的看法</h2>
</div><p>Hedge funds have recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL purchased a new stake in Tilray Brands during the 3rd quarter valued at $518,000. Optiver Holding B.V. raised its stake in Tilray Brands by 239.4% during the 3rd quarter. Optiver Holding B.V. now owns 224,049 shares of the company's stock valued at $388,000 after buying an additional 158,041 shares during the last quarter. Cresset Asset Management LLC raised its stake in Tilray Brands by 72.1% during the 3rd quarter. Cresset Asset Management LLC now owns 501,989 shares of the company's stock valued at $868,000 after buying an additional 210,267 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Tilray Brands by 99,204,800.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 992,049 shares of the company's stock valued at $1,716,000 after buying an additional 992,048 shares during the last quarter. Finally, Zuckerman Investment Group LLC purchased a new stake in Tilray Brands during the 3rd quarter valued at $147,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>对冲基金最近增加或减少了对该股票的持股。Tudor Investment Corp ET AL 在第三季度购买了价值 518,000 美元的 Tilray Brands 新股份。Optiver Holding B.V. 在第三季度将其在 Tilray Brands 的持股增加了 239.4%。Optiver Holding B.V. 目前拥有 224,049 股该公司股票，价值 388,000 美元，此前在上个季度又购买了 158,041 股。Cresset Asset Management LLC 在第三季度将其在 Tilray Brands 的持股增加了 72.1%。Cresset Asset Management LLC 目前拥有 501,989 股该公司股票，价值 868,000 美元，此前在上个季度又购买了 210,267 股。Caitong International Asset Management Co. Ltd 在第三季度将其在 Tilray Brands 的持股增加了 99,204,800.0%。Caitong International Asset Management Co. Ltd 目前拥有 992,049 股该公司股票，价值 1,716,000 美元，此前在上个季度又购买了 992,048 股。最后，Zuckerman Investment Group LLC 在第三季度购买了价值 147,000 美元的 Tilray Brands 新股份。目前，9.35% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Tilray Brands Company Profile</h2>
<div class="lb-trans"><h2>Tilray Brands 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.</p>
<div class="lb-trans"><p>Tilray Brands, Inc 是一家全球性的 cannabis-lifestyle 和消费包装商品公司，专注于大麻及其衍生产品的种植、生产、分销和销售。该公司开发和营销多样化的品牌产品组合，涵盖医疗大麻、成人娱乐产品和健康产品。通过先进的种植设施、研发努力和质量控制系统，Tilray Brands 旨在为各种患者和消费者需求提供一致、可扩展的产品。</p>
</div><p>Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.</p>
<div class="lb-trans"><p>Tilray 的产品线包括大麻花、预卷烟、油和酊剂、电子烟、食品和外用产品，以及大麻衍生的 CBD 产品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Tilray Brands</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Tilray Brands</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tilray Brands Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Tilray Brands 吗？</h2>
</div><p>Before you consider Tilray Brands, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Tilray Brands 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Tilray Brands 并不在名单上。</p>
</div><p>While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Tilray Brands 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Tilray Brands（NASDAQ:TLRY）股价下跌 2.7% - 以下是原因